Literature DB >> 28163193

The neuropathological signature of bulbar-onset ALS: A systematic review.

S Shellikeri1, V Karthikeyan2, R Martino3, S E Black4, L Zinman5, J Keith6, Y Yunusova7.   

Abstract

ALS is a multisystem disorder affecting motor and cognitive functions. Bulbar-onset ALS (bALS) may be preferentially associated with cognitive and language impairments, compared with spinal-onset ALS (sALS), stemming from a potentially unique neuropathology. The objective of this systematic review was to compare neuropathology findings reported for bALS and sALS subtypes in studies of cadaveric brains. Using Cochrane guidelines, we reviewed articles in MEDLINE, Embase, and PsycINFO databases using standardized search terms for ALS and neuropathology, from inception until July 16th 2016. 17 studies were accepted for analysis. The analysis revealed that both subtypes presented with involvement in motor and frontotemporal cortices, deep cortical structures, and cerebellum and were characterized by neuronal loss, spongiosis, myelin pallor, and ubiquitin+ and TDP43+ inclusion bodies. Changes in Broca and Wernicke areas - regions associated with speech and language processing - were noted exclusively in bALS. Further, some bALS cases presented with atypical pathology such as neurofibrillary tangles and basophilic inclusions, which were not found in sALS cases. Given the limited number of studies, all with methodological biases, further work is required to better understand neuropathology of ALS subtypes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALS subtypes; Bulbar ALS; Cognitive/language impairments; Histopathology; Neuropathology; Systematic review

Mesh:

Substances:

Year:  2017        PMID: 28163193      PMCID: PMC5425954          DOI: 10.1016/j.neubiorev.2017.01.045

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  89 in total

1.  Impaired cognitive flexibility in amyotrophic lateral sclerosis.

Authors:  Jessica Evans; Christopher Olm; Leo McCluskey; Lauren Elman; Ashley Boller; Eileen Moran; Katya Rascovsky; Teagan Bisbing; Corey T McMillan; Murray Grossman
Journal:  Cogn Behav Neurol       Date:  2015-03       Impact factor: 1.600

2.  Cognitive impairment in motor neuron disease with bulbar onset.

Authors:  F Portet; C Cadilhac; J Touchon; W Camu
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2001-03

3.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Catherine Lomen-Hoerth; Thomas Anderson; Bruce Miller
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

4.  Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis.

Authors:  D Troost; P A Sillevis Smitt; J M de Jong; D F Swaab
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 5.  The neuropathology of FTD associated With ALS.

Authors:  Ian R A Mackenzie
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

6.  Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum.

Authors:  Toshiya Nakano; Kazuhiro Nakaso; Kenji Nakashima; Eisaku Ohama
Journal:  Acta Neuropathol       Date:  2004-02-05       Impact factor: 17.088

7.  Relation between cognitive dysfunction and reduced vital capacity in amyotrophic lateral sclerosis.

Authors:  S-M Kim; K-M Lee; Y-H Hong; K S Park; J-H Yang; H-W Nam; J-J Sung; K-W Lee
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-08       Impact factor: 10.154

8.  Cognitive impairment in motor neuron disease.

Authors:  R Gallassi; P Montagna; C Ciardulli; S Lorusso; V Mussuto; A Stracciari
Journal:  Acta Neurol Scand       Date:  1985-06       Impact factor: 3.209

9.  Writing errors and anosognosia in amyotrophic lateral sclerosis with dementia.

Authors:  Hiroo Ichikawa; Shinichi Koyama; Hideki Ohno; Kenji Ishihara; Kiyomi Nagumo; Mitsuru Kawamura
Journal:  Behav Neurol       Date:  2008       Impact factor: 3.342

Review 10.  Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.

Authors:  Jeffrey D Rothstein
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  13 in total

1.  Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons.

Authors:  Filippo Ghezzi; Laura Monni; Andrea Nistri
Journal:  J Physiol       Date:  2018-05-30       Impact factor: 5.182

2.  Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.

Authors:  Francesca Trojsi; Mattia Siciliano; Cinzia Femiano; Gabriella Santangelo; Christian Lunetta; Andrea Calvo; Cristina Moglia; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialò; Gianni Sorarù; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Valeria Ada Sansone; Adriano Chiò; Gabriele Mora; Barbara Poletti; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Antonio Fasano; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Jessica Mandrioli
Journal:  J Neurol       Date:  2017-09-15       Impact factor: 4.849

3.  An exploration of neural dynamics of motor imagery for people with amyotrophic lateral sclerosis.

Authors:  Sarah M Hosni; R J Deligani; A Zisk; J McLinden; S B Borgheai; Y Shahriari
Journal:  J Neural Eng       Date:  2019-12-05       Impact factor: 5.379

4.  Safety and Clinical Benefits of Laryngeal Closure in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Sayaka Yokoi; Naoki Nishio; Takashi Maruo; Mariko Hiramatsu; Nobuaki Mukoyama; Hidenori Tsuzuki; Akihisa Wada; Naoki Atsuta; Daisuke Ito; Takashi Tsuboi; Gen Sobue; Masahisa Katsuno; Yasushi Fujimoto; Michihiko Sone
Journal:  Dysphagia       Date:  2022-05-04       Impact factor: 3.438

Review 5.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 6.  Mitophagy Modulation, a New Player in the Race against ALS.

Authors:  Enrique Madruga; Inés Maestro; Ana Martínez
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

7.  Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.

Authors:  Sanjana Shellikeri; Julia Keith; Sandra E Black; Lorne Zinman; Yana Yunusova
Journal:  J Neuropathol Exp Neurol       Date:  2020-03-01       Impact factor: 3.685

8.  Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis.

Authors:  Mengli Wang; Zhen Liu; Juan Du; Yanchun Yuan; Bin Jiao; Xuewei Zhang; Xuan Hou; Lu Shen; Jifeng Guo; Hong Jiang; Kun Xia; Jianguang Tang; Ruxu Zhang; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

9.  Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis.

Authors:  Gabriela M Stegmann; Shira Hahn; Julie Liss; Jeremy Shefner; Seward Rutkove; Kerisa Shelton; Cayla Jessica Duncan; Visar Berisha
Journal:  NPJ Digit Med       Date:  2020-10-13

10.  Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis.

Authors:  Hannelore K van der Burgh; Henk-Jan Westeneng; Renée Walhout; Kevin van Veenhuijzen; Harold H G Tan; Jil M Meier; Leonhard A Bakker; Jeroen Hendrikse; Michael A van Es; Jan H Veldink; Martijn P van den Heuvel; Leonard H van den Berg
Journal:  Neurology       Date:  2020-05-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.